{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T21:58:27Z","timestamp":1761861507178},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1996,3,1]],"date-time":"1996-03-01T00:00:00Z","timestamp":825638400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digest Dis Sci"],"published-print":{"date-parts":[[1996,3]]},"DOI":"10.1007\/bf02282352","type":"journal-article","created":{"date-parts":[[2006,1,25]],"date-time":"2006-01-25T14:00:24Z","timestamp":1138197624000},"page":"624-626","source":"Crossref","is-referenced-by-count":41,"title":["Pleuropericarditis related to the use of mesalamine"],"prefix":"10.1007","volume":"41","author":[{"given":"Navjyot","family":"Gujral","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Friedenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Friedenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morris","family":"Kotler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02282352_CR1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/cpt1972134539","volume":"13","author":"H Schroder","year":"1972","unstructured":"Schroder H, Campbell DES: Absorption, metabolism, and excretion of salicylazosulphapyridine in man. Clin Pharmacol Ther 13:539\u2013551, 1972","journal-title":"Clin Pharmacol Ther"},{"key":"BF02282352_CR2","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2165\/00003088-197601060-00002","volume":"1","author":"KM Das","year":"1976","unstructured":"Das KM, Dubin R: Clinical Pharmacokinetics of sulphasalazine. Clin Pharmacokinet 1:406\u2013425, 1976","journal-title":"Clin Pharmacokinet"},{"key":"BF02282352_CR3","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0140-6736(89)92407-0","volume":"2","author":"J Agnholt","year":"1989","unstructured":"Agnholt J, Soerensen HT, Rasmussen SN, et al: Cardiac hypersensitivity to 5-aminosalicylic acid. Lancet 2:1135, 1989","journal-title":"Lancet"},{"key":"BF02282352_CR4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1001\/archinte.1983.00350010098017","volume":"143","author":"RV Patwardhan","year":"1983","unstructured":"Patwardhan RV, Heilpern J, Brewster AD, Darra JJ: Pleuropericarditis: An extraintestinal complication of inflammatory bowel disease. Arch Intern Med 143:94\u201396, 1983","journal-title":"Arch Intern Med"},{"key":"BF02282352_CR5","first-page":"614","volume":"77","author":"D Barr-Locke","year":"1982","unstructured":"Barr-Locke D: Sulfasuxidine-induced lupus syndrome in a patient with Crohn's disease. Am J Gastroenterol 77:614\u2013615, 1982","journal-title":"Am J Gastroenterol"},{"key":"BF02282352_CR6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0002-9343(88)90279-3","volume":"84","author":"GL Clementz","year":"1988","unstructured":"Clementz GL, Dolin BJ: Sulfasalazine-induced lupus erythematosis. Am J Med 84:535\u2013538, 1988","journal-title":"Am J Med"},{"key":"BF02282352_CR7","first-page":"85","volume":"84","author":"G Deboever","year":"1989","unstructured":"Deboever G, Devogelaere R, Holvoet G: Sulfasalazine-induced lupus-like syndrome with cardiac tamponade in a patient with ulcerative colitis. Am J Gastroenterol 84:85\u201386, 1989","journal-title":"Am J Gastroenterol"},{"key":"BF02282352_CR8","unstructured":"FDA rare adverse reaction with Rowasa. FDA Drug Bull 19:17\u201318, 1989"},{"key":"BF02282352_CR9","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0140-6736(90)90387-K","volume":"335","author":"KS Kristensen","year":"1990","unstructured":"Kristensen KS, Hoegholm A, Bohr L, et al: Fatal myocarditis associated with mesalazine. Lancet 335:605, 1990","journal-title":"Lancet"},{"key":"BF02282352_CR10","first-page":"332","volume":"85","author":"H Jenss","year":"1990","unstructured":"Jenss H, Becker EW, Weber P: Pericardial effusion during treatment with 5-aminosalicylic acid in a patient with Crohn's disease. Am J Gastroenterol 85:332\u2013333, 1990","journal-title":"Am J Gastroenterol"},{"key":"BF02282352_CR11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3109\/00365528809101548","volume":"23","author":"H Sandberg-Gertzen","year":"1988","unstructured":"Sandberg-Gertzen H, Jarnerot G, Tysk C: Long-term treatment with olsalazine of ulcerative colitis: Safety and relapse prevention: A follow-up study. Scand J Gastroenterol 23:48\u201350, 1988","journal-title":"Scand J Gastroenterol"},{"key":"BF02282352_CR12","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/BF02065413","volume":"40","author":"P Miner","year":"1995","unstructured":"Miner P, Hanauer S, Robinson M, et al: Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Dig Dis Sci 40:296\u2013304, 1995","journal-title":"Dig Dis Sci"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02282352.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02282352\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02282352","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T18:44:02Z","timestamp":1557945842000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02282352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,3]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1996,3]]}},"alternative-id":["BF02282352"],"URL":"https:\/\/doi.org\/10.1007\/bf02282352","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,3]]}}}